AI assistant
Sending…
Nykode Therapeutics ASA — Director's Dealing 2021
Nov 2, 2021
3695_dirs_2021-11-02_56574961-4650-469f-bfd8-1b033674c771.pdf
Director's Dealing
Open in viewerOpens in your device viewer
| 1 | Details of the closely associated enterprise | ||||
|---|---|---|---|---|---|
| a) | Name | Kvantia AS | |||
| 2 | Details of the person discharging managerial responsibilities | ||||
| a) | Name | Christian Åbyholm | |||
| b) | Position | Board Member | |||
| 3 | Reason for notification | ||||
| b) | Initial notification/ Amendment |
Initial | |||
| 4 | Details of issuer | ||||
| a) | Name | Vaccibody AS | |||
| b) | LEI | 254900UKQHWYZJD22017 | |||
| 5 | conducted | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been |
|||
| a) | Description of the financial instrument, type of instrument |
Shares in Vaccibody AS (ISIN: NO0010714785) | |||
| b) | Nature of the transaction |
Sale of shares to closely associated enterprise | |||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | ||
| NOK 64.00 | 10,866,325 | ||||
| d) | Aggregated information | Price | NOK 64.00 | ||
| -Average price, | Volume | 10,866,325 | |||
| aggregated volume and total amount |
Total amount | NOK 695,444,800 | |||
| e) | Date of the transaction | 02.11.2021 | |||
| f) | Place of the transaction | MERK – Euronext Growth Oslo |
| 1 | Details of the closely associated enterprise | ||||
|---|---|---|---|---|---|
| a) | Name | Christiania Skibs AS | |||
| 2 | Details of the person discharging managerial responsibilities | ||||
| a) | Name | Christian Åbyholm | |||
| b) | Position | Board Member | |||
| 3 | Reason for notification | ||||
| b) | Initial notification/ Amendment |
Initial | |||
| 4 | Details of issuer | ||||
| a) | Name | Vaccibody AS | |||
| b) | LEI | 254900UKQHWYZJD22017 | |||
| 5 | conducted | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been |
|||
| a) | Description of the financial instrument, type of instrument |
Shares in Vaccibody AS (ISIN: NO0010714785) | |||
| b) | Nature of the transaction |
Sale of shares to closely associated enterprise | |||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | ||
| NOK 64.00 | 6,304,250 | ||||
| d) | Aggregated information | Price | NOK 64.00 | ||
| -Average price, | Volume | 6,304,250 | |||
| aggregated volume and total amount |
Total amount | NOK 403,472,000 | |||
| e) | Date of the transaction | 02.11.2021 | |||
| f) | Place of the transaction | MERK – Euronext Growth Oslo |
| 1 | Details of the closely associated enterprise | ||||
|---|---|---|---|---|---|
| a) | Name | Victoria India Fund AS | |||
| 2 | Details of the person discharging managerial responsibilities | ||||
| a) | Name | Christian Åbyholm | |||
| b) | Position | Board Member | |||
| 3 | Reason for notification | ||||
| b) | Initial notification/ Amendment |
Initial | |||
| 4 | Details of issuer | ||||
| a) | Name | Vaccibody AS | |||
| b) | LEI | 254900UKQHWYZJD22017 | |||
| 5 | conducted | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been |
|||
| a) | Description of the financial instrument, type of instrument |
Shares in Vaccibody AS (ISIN: NO0010714785) | |||
| b) | Nature of the transaction |
Acquisition of shares from closely associated enterprise | |||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | ||
| NOK 64.00 | 17,170,575 | ||||
| d) | Aggregated information | Price | NOK 64.00 | ||
| -Average price, | Volume | 17,170,575 | |||
| aggregated volume and total amount |
Total amount | NOK 1,098,916,800 | |||
| e) | Date of the transaction | 02.11.2021 | |||
| f) | Place of the transaction | MERK – Euronext Growth Oslo |
More from Nykode Therapeutics ASA
Report Publication Announcement
2026
May 18
Report Publication Announcement
2026
May 18
Declaration of Voting Results & Voting Rights Announcements
2026
May 13
Report Publication Announcement
2026
May 13
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 21
AGM Information
2026
Apr 21